statistiche ricercatore

CLEMENTI, MASSIMO

Distribuzione geografica

Continente	#
NA - Nord America	2.431
AS - Asia	1.663
EU - Europa	1.663
Continente sconosciuto - Info sul continente non disponibili	208
SA - Sud America	174
AF - Africa	31
OC - Oceania	5
Totale	6.175

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	2.329
IT - Italia	1.045
SG - Singapore	708
CN - Cina	411
HK - Hong Kong	255
BR - Brasile	151
VN - Vietnam	129
GB - Regno Unito	110
FR - Francia	92
DE - Germania	89
FI - Finlandia	81
IE - Irlanda	76
RU - Federazione Russa	75
CA - Canada	53
MX - Messico	39
IN - India	37
BD - Bangladesh	28
JP - Giappone	19
NL - Olanda	14
PL - Polonia	14
ES - Italia	11
IQ - Iraq	11
SE - Svezia	11
TR - Turchia	11
AT - Austria	10
SA - Arabia Saudita	10
KE - Kenya	8
ZA - Sudafrica	8
AR - Argentina	7
BE - Belgio	7
LT - Lituania	6
NG - Nigeria	6
CH - Svizzera	5
AE - Emirati Arabi Uniti	4
AU - Australia	4
CO - Colombia	4
JO - Giordania	4
MD - Moldavia	4
UA - Ucraina	4
AZ - Azerbaigian	3
CR - Costa Rica	3
ID - Indonesia	3
MA - Marocco	3
PK - Pakistan	3
UZ - Uzbekistan	3
VE - Venezuela	3
BG - Bulgaria	2
CL - Cile	2
DK - Danimarca	2
EC - Ecuador	2
EG - Egitto	2
GE - Georgia	2
IL - Israele	2
KR - Corea	2
KZ - Kazakistan	2
LB - Libano	2
PE - Perù	2
PH - Filippine	2
QA - Qatar	2
VC - Saint Vincent e Grenadine	2
BH - Bahrain	1
BO - Bolivia	1
BY - Bielorussia	1
BZ - Belize	1
CG - Congo	1
CI - Costa d'Avorio	1
CY - Cipro	1
ET - Etiopia	1
GN - Guinea	1
GR - Grecia	1
IR - Iran	1
JM - Giamaica	1
KG - Kirghizistan	1
MM - Myanmar	1
MY - Malesia	1
NC - Nuova Caledonia	1
NI - Nicaragua	1
NP - Nepal	1
OM - Oman	1
PS - Palestinian Territory	1
PY - Paraguay	1
RS - Serbia	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
TT - Trinidad e Tobago	1
UY - Uruguay	1
Totale	5.967

Salva come PNG Salva come JPEG

Città	#
Milan	684
San Jose	530
Singapore	373
Ashburn	285
Council Bluffs	276
Hong Kong	252
Chicago	168
Beijing	156
The Dalles	120
Dallas	101
Boardman	92
Dublin	76
London	75
Helsinki	71
Lauterbourg	71
Los Angeles	69
Rome	61
Ho Chi Minh City	43
Santa Clara	39
Hanoi	33
New York	33
Mexico City	29
Munich	27
Washington	27
Ogden	26
Frankfurt am Main	21
Brooklyn	20
Seattle	20
Orem	18
Tokyo	18
Varese	17
San Francisco	14
Warsaw	14
Chennai	13
Como	13
Atlanta	12
Shanghai	12
Toronto	12
Guangzhou	10
Montreal	10
Nuremberg	10
São Paulo	10
Denver	8
Nairobi	8
Shenzhen	8
Vancouver	8
Vienna	8
Amsterdam	7
Boston	7
Brussels	7
Dhaka	7
Phoenix	7
Pittsburgh	7
Pune	7
Abuja	6
Ankara	6
Da Nang	6
Hangzhou	6
Houston	6
Johannesburg	6
Minesing	6
New Delhi	6
Poplar	6
Berlin	5
Düsseldorf	5
Falkenstein	5
Haiphong	5
Magnago	5
Miami	5
North Bergen	5
Querétaro	5
Rio de Janeiro	5
Amman	4
Baghdad	4
Bari	4
Belo Horizonte	4
Bodio Lomnago	4
Brescia	4
Cernusco sul Naviglio	4
Chiswick	4
Detroit	4
Greensboro	4
Jeddah	4
Mumbai	4
Newark	4
Riyadh	4
Salt Lake City	4
Sulmona	4
Turku	4
West Jordan	4
Alexandria	3
Blumenau	3
Brasília	3
Campinas	3
Changsha	3
Charlotte	3
Fortaleza	3
Goiânia	3
Hải Dương	3
Indianapolis	3
Totale	4.251

Salva come PNG Salva come JPEG

Nome	#
A biologically-validated HCV E1E2 heterodimer structural model	125
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes	119
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19	115
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)	115
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases	111
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs	111
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies	107
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients	107
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine	105
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes	104
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses	104
A case of psoriatic arthritis triggered by SARS-CoV-2 infection	103
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections	102
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools	101
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies	101
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein	101
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2	100
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes	94
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections	93
Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study	93
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens	92
A human stem cell-derived neurosensory–epithelial circuitry on a chip to model herpes simplex virus reactivation	91
Answer to photo quiz: Streptococcus pneumoniae	89
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study	87
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion?	87
The interferon landscape along the respiratory tract impacts the severity of COVID-19	87
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches	86
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?	85
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects	84
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome	84
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference	84
Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro	83
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials	80
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital	80
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)	79
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice	78
Viral respiratory pathogens and lung Injury	78
IFCC interim guidelines on molecular testing of SARS-CoV-2 infection	77
Microbiome markers are early predictors of acute GvHD in allogeneic hematopoietic stem cell transplant recipients	76
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients	75
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia	74
Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?	73
Risks of "blind" automated identification systems in medical microbiology	72
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes	72
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection	72
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects	71
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death	71
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy	69
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity	69
Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies	68
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab	67
HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role	66
Characterization of four major human B-cell epitopes on the surface of HCV E2 glycoprotein by generation of human monoclonal Fab from phage display antibody librariesis	65
Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis Virus/HCV pseudotype	65
IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients	63
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle	60
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines	60
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge	60
Role and potential therapeutic use of antibodies against herpetic infections	60
Modulation of epitope-specific anti-hepatitis C virus E2 (Anti-HCV/E2) antibodies by anti-viral treatment	57
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site on gp120SITE ON GP120	57
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin	56
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection	56
Nanosphere's Verigene (R) System to detect Multidrug-Resistant Gram-negative Bacterial Outbreak: a prospective study in 60 patients	53
Human Monoclonal Antibody able to nneutralize a broad range of H1 and H3 subtype influenza A viruses	53
Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs	52
Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial	51
Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients	49
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room	49
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System	48
Molecular dissection of the IGM/K antibody repertoire in an HCV-infected patient with cryoglobulinemia	47
Molecular Cloning of a Human Monoclonal Antibody neutralizing a broad range of H1 subtype influenza virus including swine-origin influenza virus (S-OIV)	47
Microbiological Diagnosis of Sepsis: The Confounding Effects of a “Gold Standard”	47
Rapid Molecular Detection of Pathogens in 516 Consecutive Haematological Patients with Febrile Neutropenia	46
Oral and Fecal Microbiota in Lynch Syndrome	44
Evaluation of a synergistic interactions of anti-E2/HCV monoclonal antibodies	41
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients	41
Definition of biological activity and quantitation of different families of human anti-HCV/E2 antibodies by generation of human recombinant anti-E2 monoclonal Fab by phage display combinatorial repertoire library	41
Rational dosing strategies of colistin: what about resistance?	40
Molecular dissection of the human humoral response against HCV E2 glycoprotein by cloning of the antibody repertoire in phage display combinatorial vectors	40
RAPID MOLECULAR DETECTION OF PATHOGENS IN 1941 BLOOD SAMPLES FROM 516 CONSECUTIVE PATIENTS WITH FEBRILE NEUTROPENIA	39
Multiplex PCR-based assay (SeptiFast) for rapid detection of pathogens in febrile neutropenia: results in 273 consecutive patients	36
Molecular Diagnosis of Scedosporium apiospermum Keratitis	35
Totale	6.175

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	35.103
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	35.103

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	232	0	0	0	0	0	0	0	0	123	71	20	18
2023/2024	1.288	163	195	164	256	300	87	7	25	35	35	9	12
2024/2025	1.248	9	38	262	62	46	68	55	57	155	75	92	329
2025/2026	3.157	288	168	156	390	203	125	717	157	433	205	165	150
2026/2027	250	54	152	44	0	0	0	0	0	0	0	0	0
Totale													6.175